| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.33B | +17.5% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.03B | — |
| Net income | ¥0.03B | -39.7% |
| Gross margin | 28.6% | Net margin 9.0% |
| Revenue Q/Q | +38.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.23B | 71.4% |
| R&D | ¥0.01B | 4.1% |
| SG&A | ¥0.02B | 6.7% |
| Tax & other | ¥0.00B | 1.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
港通医疗 ・ 中远通 ・ 陕西华达 ・ 长华化学 ・ 舜禹股份 ・ 万邦医药 ・ 上大股份 ・ 儒竞科技 ・ 国际复材 ・ 多浦乐 ・ 福赛科技 ・ 春光集团
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies